Correlation Between Pharmaceuticals Ultrasector and Principal Lifetime

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Principal Lifetime at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Principal Lifetime into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Principal Lifetime Hybrid, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Principal Lifetime and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Principal Lifetime. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Principal Lifetime.

Diversification Opportunities for Pharmaceuticals Ultrasector and Principal Lifetime

0.73

Correlation Coefficient

Pharmaceuticals Ultrasector  Principal Lifetime

Poor diversification

The 3 months correlation between Pharmaceuticals and Principal is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Principal Lifetime Hybrid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Principal Lifetime Hybrid and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Principal Lifetime. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Principal Lifetime Hybrid has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Principal Lifetime go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Principal Lifetime

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 1.72 times more return on investment than Principal Lifetime. However, Pharmaceuticals Ultrasector is 1.72 times more volatile than Principal Lifetime Hybrid. It trades about -0.02 of its potential returns per unit of risk. Principal Lifetime Hybrid is currently generating about -0.03 per unit of risk. If you would invest  2,445  in Pharmaceuticals Ultrasector Profund on December 30, 2024 and sell it today you would lose (54.00) from holding Pharmaceuticals Ultrasector Profund or give up 2.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Principal Lifetime Hybrid

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Pharmaceuticals Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Principal Lifetime Hybrid

Risk-Adjusted Performance

Very Weak

Over the last 90 days Principal Lifetime Hybrid has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Principal Lifetime is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pharmaceuticals Ultrasector and Principal Lifetime

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Principal Lifetime positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Principal Lifetime can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Principal Lifetime will offset losses from the drop in Principal Lifetime's long position.

The idea behind Pharmaceuticals Ultrasector Profund and Principal Lifetime Hybrid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.